AUB ScholarWorks

A feasibility study of a new method for electrically producing seizures in man: Focal electrically administered seizure therapy [FEAST]

Show simple item record

dc.contributor.author Nahas Z.
dc.contributor.author Short B.
dc.contributor.author Burns C.
dc.contributor.author Archer M.
dc.contributor.author Schmidt M.
dc.contributor.author Prudic J.
dc.contributor.author Nobler M.S.
dc.contributor.author Devanand D.P.
dc.contributor.author Fitzsimons L.
dc.contributor.author Lisanby S.H.
dc.contributor.author Payne N.
dc.contributor.author Perera T.
dc.contributor.author George M.S.
dc.contributor.author Sackeim H.A.
dc.contributor.editor
dc.date May-2013
dc.date.accessioned 2017-10-05T16:04:44Z
dc.date.available 2017-10-05T16:04:44Z
dc.date.issued 2013
dc.identifier 10.1016/j.brs.2013.03.004
dc.identifier.isbn
dc.identifier.issn
dc.identifier.uri http://hdl.handle.net/10938/19661
dc.description.abstract Background: Electroconvulsive therapy (ECT) remains the most effective acute treatment for severe major depression, but with significant risk of adverse cognitive effects. Unidirectional electrical stimulation with a novel electrode placement and geometry (Focal Electrically Administered Seizure Therapy (FEAST)) has been proposed as a means to initiate seizures in prefrontal cortex prior to secondary generalization. As such, it may have fewer cognitive side effects than traditional ECT. We report on its first human clinical application. Method: Seventeen unmedicated depressed adults (5 men; 3 bipolar disorder; age 53 ± 16 years) were recruited after being referred for ECT. Open-label FEAST was administered with a modified spECTrum 5000Q device and a traditional ECT dosing regimen until patients clinically responded. Clinical and cognitive assessments were obtained at baseline, and end of course. Time to orientation recovery, a predictor of long-term amnestic effects, was assessed at each treatment. Nonresponders to FEAST were transitioned to conventional ECT. Results: One patient withdrew from the study after a single titration session. After the course of FEAST (median 10 sessions), there was a 46.1 ± 35.5percent improvement in Hamilton Rating Scale for Depression (HRSD24) scores compared to baseline (33.1 ± 6.8, 16.8 ± 10.9; P andlt; 0.0001). Eight of 16 patients met response criteria (50percent decrease in HRSD24) and 5-16 met remission criteria (HRSD24 ≤ 10). Patients achieved full re-orientation (4 of 5 items) in 5.5 ± 6.4 min (median = 3.6), timed from when their eyes first opened after treatment. Conclusion: In this feasibility study, FEAST produced clinically meaningful antidepressant improvement, with relatively short time to reorientation. Our preliminary work first in primates and now depressed adults demonstrates that FEAST is feasible, safe, well-tolerated and, if efficacy can be optimized, has potential to replace traditional ECT. © 2013 Elsevier Inc. All rights reserved.
dc.format.extent
dc.format.extent Pages: (403-408)
dc.language English
dc.publisher NEW YORK
dc.relation.ispartof Publication Name: Brain Stimulation; Publication Year: 2013; Volume: 6; no. 3; Pages: (403-408);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title A feasibility study of a new method for electrically producing seizures in man: Focal electrically administered seizure therapy [FEAST]
dc.type Article
dc.contributor.affiliation Nahas, Z., Department of Psychiatry, American University of Beirut, Beirut, Lebanon, Medical University of South Carolina, SC, United States
dc.contributor.affiliation Short, B., Medical University of South Carolina, SC, United States
dc.contributor.affiliation Burns, C., Medical University of South Carolina, SC, United States
dc.contributor.affiliation Archer, M., Medical University of South Carolina, SC, United States
dc.contributor.affiliation Schmidt, M., Medical University of South Carolina, SC, United States
dc.contributor.affiliation Prudic, J., Department of Psychiatry, Columbia University, NY, United States
dc.contributor.affiliation Nobler, M.S., Department of Psychiatry and Behavioral Sciences, New York Medical College, NY, United States
dc.contributor.affiliation Devanand, D.P., Department of Psychiatry, Columbia University, NY, United States
dc.contributor.affiliation Fitzsimons, L., Department of Psychiatry, Columbia University, NY, United States
dc.contributor.affiliation Lisanby, S.H., Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, NC, United States
dc.contributor.affiliation Payne, N., New York University, NY, United States
dc.contributor.affiliation Perera, T., Department of Psychiatry, Columbia University, NY, United States
dc.contributor.affiliation George, M.S., Medical University of South Carolina, SC, United States, Ralph H. Johnson VA Medical Center, Charleston, SC, United States
dc.contributor.affiliation Sackeim, H.A., Department of Psychiatry, Columbia University, NY, United States
dc.contributor.authorAddress Nahas, Z.; American University of Beirut, P.O. Box, Beirut, Lebanon; email: zn17@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Psychiatry;
dc.contributor.authorDepartment Psychiatry
dc.contributor.authorDivision
dc.contributor.authorEmail zn17@aub.edu.lb
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Nahas, Z
dc.contributor.authorInitials Short, B
dc.contributor.authorInitials Burns, C
dc.contributor.authorInitials Archer, M
dc.contributor.authorInitials Schmidt, M
dc.contributor.authorInitials Prudic, J
dc.contributor.authorInitials Nobler, MS
dc.contributor.authorInitials Devanand, DP
dc.contributor.authorInitials Fitzsimons, L
dc.contributor.authorInitials Lisanby, SH
dc.contributor.authorInitials Payne, N
dc.contributor.authorInitials Perera, T
dc.contributor.authorInitials George, MS
dc.contributor.authorInitials Sackeim, HA
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Nahas, Z (reprint author), Amer Univ Beirut, Beirut, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited ACKERMANN RF, 1986, ANN NY ACAD SCI, V462, P263, DOI 10.1111-j.1749-6632.1986.tb51260.x; AMASSIAN VE, 1991, ELECTROEN CLIN NEURO, P3; AMASSIAN VE, 1992, ELECTROEN CLIN NEURO, V85, P291, DOI 10.1016-0168-5597(92)90105-K; AMASSIAN VE, 1989, EXP NEUROL, V103, P282; AMASSIAN VE, 1990, ELECTROEN CLIN NEURO, V77, P390, DOI 10.1016-0168-5597(90)90061-H; Bai SW, 2012, BRAIN STIMUL, V5, P408, DOI 10.1016-j.brs.2011.07.004; BARKER AT, 1985, LANCET, V1, P1106; Berman RM, 2008, BRAIN STIMUL, V1, P16, DOI 10.1016-j.brs.2007.08.005; Boylan LS, 2001, J ECT, V17, P175, DOI 10.1097-00124509-200109000-00005; BUSCHKE H, 1974, NEUROLOGY, V24, P1019; COHEN LG, 1990, ELECTROEN CLIN NEURO, V75, P350, DOI 10.1016-0013-4694(90)90113-X; CRACCO RQ, 1989, ELECTROEN CLIN NEURO, V74, P417, DOI 10.1016-0168-5597(89)90030-0; Deng ZD, 2011, J NEURAL ENG, V8, DOI 10.1088-1741-2560-8-1-016007; DSM-IV, 1994, DIAGN STAT MAN MENT; Engel JJ, 1987, EPILEPTIC FOCUS, P83; Engel JJ, 1989, SEIZURES EPILEPSY; Epstein CM, 2002, J CLIN NEUROPHYSIOL, V19, P376, DOI 10.1097-00004691-200208000-00010; George MS, 1999, ARCH GEN PSYCHIAT, V56, P300, DOI 10.1001-archpsyc.56.4.300; HAYES KJ, 1950, ARCH NEURO PSYCHIATR, V63, P102; Kayser S, 2011, J PSYCHIATR RES, V45, P569, DOI 10.1016-j.jpsychires.2010.09.008; Lee WH, 2012, NEUROIMAGE, V59, P2110, DOI 10.1016-j.neuroimage.2011.10.029; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056-NEJMct075234; Maccabee PJ, 1998, J PHYSIOL-LONDON, V513, P571, DOI 10.1111-j.1469-7793.1998.571bb.x; MACCABEE PJ, 1993, J PHYSIOL-LONDON, V460, P201; MACCABEE PJ, 1991, ELECTROEN CLIN NEURO, P344; Nobler MS, 2001, AM J PSYCHIAT, V158, P305, DOI 10.1176-appi.ajp.158.2.305; Peterchev AV, 2010, J ECT, V26, P159, DOI 10.1097-YCT.0b013e3181e48165; POSNER JB, 1969, ARCH NEUROL-CHICAGO, V20, P388; PRINCE DA, 1967, ARCH NEUROL-CHICAGO, V16, P194; SACKEIM H, 1987, ARCH GEN PSYCHIAT, V44, P355; Sackeim HA, 1999, J ECT, V15, P5; SACKEIM HA, 1991, PSYCHIAT CLIN N AM, V14, P803; Sackeim HA, 2000, ARCH GEN PSYCHIAT, V57, P425, DOI 10.1001-archpsyc.57.5.425; SACKEIM HA, 1993, NEW ENGL J MED, V328, P839, DOI 10.1056-NEJM199303253281204; SACKEIM HA, 1987, AM J PSYCHIAT, V144, P1449; SACKEIM HA, 1994, CONVULSIVE THER, V10, P93; SACKEIM HA, 1987, BIOL PSYCHIAT, V22, P249, DOI 10.1016-0006-3223(87)90144-2; Sackeim HA, 2008, BRAIN STIMUL, V1, P71, DOI 10.1016-j.brs.2008.03.001; Sackeim Harold A., 2001, Journal of Clinical Psychiatry, V62, P10; Sackeim HA, 1996, ARCH GEN PSYCHIAT, V53, P814; Sackeim HA, 2004, CLIN NEUROSCI RES, V4, P39, DOI 10.1016-j.cnr.2004.06.013; SOBIN C, 1995, AM J PSYCHIAT, V152, P995; Spellman T, 2009, NEUROPSYCHOPHARMACOL, V34, P2002, DOI 10.1038-npp.2009.12; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thickbroom GW, 1998, ELECTROMYOGR MOTOR C, V109, P79, DOI 10.1016-S0924-980X(98)00006-X; WEAVER L, 1976, BIOL PSYCHIAT, V11, P303
dc.description.citedCount 7
dc.description.citedTotWOSCount 8
dc.description.citedWOSCount 8
dc.format.extentCount 6
dc.identifier.articleNo
dc.identifier.coden
dc.identifier.pubmedID 23518262
dc.identifier.scopusID 84877790690
dc.identifier.url
dc.publisher.address 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Brain Stimul.
dc.relation.ispartOfIssue 3
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Brain Stimulation
dc.relation.ispartofPubTitleAbbr Brain Stimul.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 6
dc.source.ID WOS:000325671700026
dc.type.publication Journal
dc.subject.otherAuthKeyword Depression
dc.subject.otherAuthKeyword ECT
dc.subject.otherAuthKeyword FEAST
dc.subject.otherAuthKeyword Seizure
dc.subject.otherChemCAS
dc.subject.otherIndex adult
dc.subject.otherIndex aged
dc.subject.otherIndex article
dc.subject.otherIndex bipolar disorder
dc.subject.otherIndex burn
dc.subject.otherIndex clinical article
dc.subject.otherIndex clinical assessment
dc.subject.otherIndex cognition
dc.subject.otherIndex depression
dc.subject.otherIndex electroconvulsive therapy
dc.subject.otherIndex electrode
dc.subject.otherIndex electroencephalogram
dc.subject.otherIndex feasibility study
dc.subject.otherIndex female
dc.subject.otherIndex Hamilton scale
dc.subject.otherIndex human
dc.subject.otherIndex male
dc.subject.otherIndex priority journal
dc.subject.otherIndex seizure
dc.subject.otherIndex treatment outcome
dc.subject.otherIndex treatment response
dc.subject.otherIndex Aged
dc.subject.otherIndex Electroconvulsive Therapy
dc.subject.otherIndex Electrodes
dc.subject.otherIndex Feasibility Studies
dc.subject.otherIndex Female
dc.subject.otherIndex Humans
dc.subject.otherIndex Male
dc.subject.otherIndex Middle Aged
dc.subject.otherIndex Neuropsychological Tests
dc.subject.otherIndex Orientation
dc.subject.otherIndex Seizures
dc.subject.otherIndex Treatment Outcome
dc.subject.otherIndex Primates
dc.subject.otherKeywordPlus TRANSCRANIAL MAGNETIC STIMULATION
dc.subject.otherKeywordPlus ELECTROCONVULSIVE-THERAPY
dc.subject.otherKeywordPlus ELECTRODE PLACEMENT
dc.subject.otherKeywordPlus PERIPHERAL-NERVE
dc.subject.otherKeywordPlus MOTOR CORTEX
dc.subject.otherKeywordPlus STIMULUS-INTENSITY
dc.subject.otherKeywordPlus COIL STIMULATION
dc.subject.otherKeywordPlus ECT
dc.subject.otherKeywordPlus EFFICACY
dc.subject.otherKeywordPlus MECHANISMS
dc.subject.otherWOS Clinical Neurology
dc.subject.otherWOS Neurosciences


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account